Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 78 (2-3) , 167-182
- https://doi.org/10.1016/0021-9150(89)90221-9
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Effect of fenofibrate treatment on type III hyperlipoproteinemiaThe American Journal of Medicine, 1987
- Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assayClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and TreatmentAnnals of Internal Medicine, 1983
- Alterations of HDL cholesterol distribution induced by incubation of human serumBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- The independent synthesis of intermediate density lipoproteins in type III hyperlipoproteinemiaMetabolism, 1982
- Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.Journal of Clinical Investigation, 1981
- Polymorphism of apolipoprotein EClinical Genetics, 1979
- TYPE-III HYPERLIPOPROTEINÆMIA ("REMNANT REMOVAL DISEASE")The Lancet, 1977
- Type III Hyperlipoproteinemia: An Analysis of Two Contemporary DefinitionsAnnals of Internal Medicine, 1975
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955